Literature DB >> 2185487

Pharmacology of cyclosporine (sandimmune). I. Introduction.

J F Borel1, F Di Padova, J Mason, V Quesniaux, B Ryffel, R Wenger.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2185487

Source DB:  PubMed          Journal:  Pharmacol Rev        ISSN： 0031-6997            Impact factor:   25.468


× No keyword cloud information.
  11 in total

Review 1.  Transcription factors as drug targets: opportunities for therapeutic selectivity.

Authors:  T R Butt; S K Karathanasis
Journal:  Gene Expr       Date:  1995

2.  Cyclosporin A reduces canalicular membrane fluidity and regulates transporter function in rats.

Authors:  S Yasumiba; S Tazuma; H Ochi; K Chayama; G Kajiyama
Journal:  Biochem J       Date:  2001-03-15       Impact factor: 3.857

3.  Comparison of the properties of the CsA analogs monoacetyl CyC (o-acetyl-threonine2 cyclosporin) and methyl-alanyl CsA (N-methyl-L-alanyl6 cyclosporin); monoacetyl cyclosporin is immunosuppressive without binding to cyclophilin.

Authors:  S el Rouby; Y Shi; G H Reem
Journal:  Clin Exp Immunol       Date:  1992-07       Impact factor: 4.330

4.  Difference between aortic and renal vascular reactivity in cyclosporin A treated rats and the effect of cicletanine.

Authors:  E O Mikkelsen; S H Poulsen; N C Nyborg; N Korsgaard; J Sehested
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-03       Impact factor: 3.000

5.  Cyclosporine inhibits flavivirus replication through blocking the interaction between host cyclophilins and viral NS5 protein.

Authors:  Min Qing; Feng Yang; Bo Zhang; Gang Zou; John M Robida; Zhiming Yuan; Hengli Tang; Pei-Yong Shi
Journal:  Antimicrob Agents Chemother       Date:  2009-05-18       Impact factor: 5.191

6.  Inhibition of human immunodeficiency virus type 1 replication in human cells by Debio-025, a novel cyclophilin binding agent.

Authors:  Roger G Ptak; Philippe A Gallay; Dirk Jochmans; Andrew P Halestrap; Urs T Ruegg; Luke A Pallansch; Michael D Bobardt; Marie-Pierre de Béthune; Johan Neyts; Erik De Clercq; Jean-Maurice Dumont; Pietro Scalfaro; Kamel Besseghir; Roland M Wenger; Brigitte Rosenwirth
Journal:  Antimicrob Agents Chemother       Date:  2008-01-22       Impact factor: 5.191

7.  Mode of action of SDZ NIM 811, a nonimmunosuppressive cyclosporin A analog with activity against human immunodeficiency virus type 1 (HIV-1): interference with early and late events in HIV-1 replication.

Authors:  A Steinkasserer; R Harrison; A Billich; F Hammerschmid; G Werner; B Wolff; P Peichl; G Palfi; W Schnitzel; E Mlynar
Journal:  J Virol       Date:  1995-02       Impact factor: 5.103

8.  Cytotoxic effects of FK506 on human renal proximal tubule cells in culture.

Authors:  M M Atcherson; A L Trifillis
Journal:  In Vitro Cell Dev Biol Anim       Date:  1994-09       Impact factor: 2.416

9.  Inhibition of human immunodeficiency virus type 1 replication by SDZ NIM 811, a nonimmunosuppressive cyclosporine analog.

Authors:  B Rosenwirth; A Billich; R Datema; P Donatsch; F Hammerschmid; R Harrison; P Hiestand; H Jaksche; P Mayer; P Peichl
Journal:  Antimicrob Agents Chemother       Date:  1994-08       Impact factor: 5.191

10.  Heteropterys tomentosa (A. Juss.) infusion counteracts Cyclosporin a side effects on the ventral prostate.

Authors:  Karine M Freitas; Juliana C Monteiro; Marcos L M Gomes; Sebastião R Taboga; Heidi Dolder
Journal:  BMC Complement Altern Med       Date:  2013-02-13       Impact factor: 3.659
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.